Zhang, Y., Yang, B., Tu, C., Ping, Y., Chen, S., Wu, T., . . . Sun, X. (2023). Mitochondrial impairment and downregulation of Drp1 phosphorylation underlie the antiproliferative and proapoptotic effects of alantolactone on oral squamous cell carcinoma cells. Journal of Translational Medicine, 21(1), 1. https://doi.org/10.1186/s12967-023-04188-2
Chicago Style (17th ed.) CitationZhang, Yafei, et al. "Mitochondrial Impairment and Downregulation of Drp1 Phosphorylation Underlie the Antiproliferative and Proapoptotic Effects of Alantolactone on Oral Squamous Cell Carcinoma Cells." Journal of Translational Medicine 21, no. 1 (2023): 1. https://doi.org/10.1186/s12967-023-04188-2.
MLA (9th ed.) CitationZhang, Yafei, et al. "Mitochondrial Impairment and Downregulation of Drp1 Phosphorylation Underlie the Antiproliferative and Proapoptotic Effects of Alantolactone on Oral Squamous Cell Carcinoma Cells." Journal of Translational Medicine, vol. 21, no. 1, 2023, p. 1, https://doi.org/10.1186/s12967-023-04188-2.